Comparing efficacy of reduced-toxicity allogeneic hematopoietic cell transplantation with conventional chemo-(immuno) therapy in patients with relapsed or refractory CLL: a Markov decision analysis

Bone Marrow Transplantation
Mohamed A Kharfan-DabajaB Djulbegovic

Abstract

Despite therapeutic advances, relapsed/refractory CLL, particularly after fludarabine-based regimens, remains a major challenge for which optimal therapy is undefined. No randomized comparative data exist to suggest the superiority of reduced-toxicity allogeneic hematopoietic cell transplantation (RT-allo-HCT) over conventional chemo-(immuno) therapy (CCIT). By using estimates from a systematic review and by meta-analysis of available published evidence, we constructed a Markov decision model to examine these competing modalities. Cohort analysis demonstrated superior outcome for RT-allo-HCT, with a 10-month overall life expectancy (and 6-month quality-adjusted life expectancy (QALE)) advantage over CCIT. Although the model was sensitive to changes in base-case assumptions and transition probabilities, RT-allo-HCT provided superior overall life expectancy through a range of values supported by the meta-analysis. QALE was superior for RT-allo-HCT compared with CCIT. This conclusion was sensitive to change in the anticipated state utility associated with the post-allogeneic HCT state; however, RT-allo-HCT remained the optimal strategy for values supported by existing literature. This analysis provides a quantitative comparison of...Continue Reading

References

Apr 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M S TallmanD Variakojis
Apr 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A OsterborgH Mellstedt
Apr 4, 2000·Bone Marrow Transplantation·Z S PavleticM R Bishop
Jan 3, 2001·The New England Journal of Medicine·H DöhnerP Lichter
Feb 24, 2001·Journal of Cancer Research and Clinical Oncology·R KathK Höffken
Jun 12, 2002·Bone Marrow Transplantation·K C DoneyUNKNOWN Seattle Bone Marrow Transplant Team
Sep 14, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K R RaiL Brettman
Dec 11, 2002·British Journal of Haematology·Francesc BoschUNKNOWN GELCAB (Grup per l'Estudi dels Limfomes a Catalunya i Balears)
May 2, 2003·The New England Journal of Medicine·Marta CrespoEmili Montserrat
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J ScheteligUNKNOWN Cooperative German Transplant Study Group
Aug 12, 2003·Cancer·Alessandra FerrajoliMichael J Keating
Mar 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William WierdaMichael Keating
Jul 27, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven Z PavleticClaudio Anasetti
Sep 8, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas ElterAndreas Engert
Mar 8, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicole LamannaMark A Weiss
Oct 21, 2006·Cancer·Michael FieglUNKNOWN Austrian Collaborative Study Group on Alemtuzumab in Chronic Lymphocytic Leukemia
Nov 7, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jennifer R BrownEdwin P Alyea
Feb 14, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan O'BrienKanti R Rai
Mar 27, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mohamed A Kharfan-DabajaEdgardo S Santos
Aug 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Johannes ScheteligPeter Dreger
Sep 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mohamed L SorrorDavid G Maloney
Jan 29, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·John G Gribben
Mar 25, 2009·Bone Marrow Transplantation·E PeresS Mineishi
Sep 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan O'BrienKanti R Rai
Oct 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas S LinJohn C Byrd

❮ Previous
Next ❯

Citations

Dec 12, 2012·Current Hematologic Malignancy Reports·Chitra HosingElizabeth Shpall
Oct 26, 2013·Leukemia·M A Kharfan-DabajaL J N Cooper
Oct 14, 2014·Leukemia & Lymphoma·Racquel D Innis-SheltonShin Mineishi
Apr 9, 2013·Hematology/oncology Clinics of North America·Peter Dreger, UNKNOWN European Group for Blood and Marrow Transplantation (EBMT)
Mar 15, 2016·Immunotherapy·Taiga NishihoriMohamed A Kharfan-Dabaja
Feb 4, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marcie Riches Tomblyn
Apr 27, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mohamed A Kharfan-DabajaMehdi Hamadani
Dec 7, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marcie Riches Tomblyn
Sep 2, 2014·Leukemia Research·Cynthia L Toze, Alina S Gerrie
Feb 6, 2015·Current Hematologic Malignancy Reports·Peter DregerUNKNOWN European Research Initiative on CLL (ERIC)
Oct 11, 2014·Blood·Peter DregerUNKNOWN European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT)
Oct 16, 2016·Best Practice & Research. Clinical Haematology·Mohamed A Kharfan-DabajaErnesto Ayala
Oct 18, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mohamed A Kharfan-DabajaBipin N Savani
Oct 18, 2014·Therapeutic Advances in Hematology·Prerna Mewawalla, Sunita Nathan
Sep 6, 2012·Bone Marrow Transplantation·R P Gale
Jan 6, 2016·AAPS PharmSciTech·Vijaykumar NekkantiGuru V Betageri
May 13, 2018·Blood·John G Gribben
Jul 3, 2021·Journal of Clinical Medicine·Shenmiao YangRobert Peter Gale

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.